For many years, surgical mesh was routinely implanted in women who underwent pelvic organ prolapse (POP) or stress urinary incontinence (SUI) surgery. Mesh manufacturers boasted that their products were wondrous: Improving the success of surgeries while reducing healing time - all without a threat of serious side effects. Some transvaginal mesh manufacturers funded medical studies to help support their claims in the medical community.
Unfortunately, doctors were largely convinced by the hype and surgeons began routinely implanting women with surgical mesh devices, or bladder slings. The U.S. Food & Drug Administration (FDA) didn't scrutinize the products either, choosing to rely on mesh's past use in hernia repair operations as proof of its safety for vaginal use.
